REPROCELL

Booth 1353
Kanagawa, Japan
REPROCELL's corporate vision is to promote human health by providing cutting-edge products, services, and partnerships that advance the future of Regenerative Medicine.

At REPROCELL, we manufacture custom GMP iPSC – Master Cell Banks (MCB) compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. The Seed iPSC Clones for MCB generation are made with our 4th Generation mRNA reprogramming technology and are available for the Sponsor to evaluate for suitability before MCB generation, or we can prepare a custom Seed Clone bank to meet the Sponsor's specifications.

Our Pharmacology Services offer a REPROCELL Biopta's safety, efficacy, and ADME preclinical assay services using fresh and functional diseased and/or healthy human tissue.

Our Central Laboratory Services offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, we deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research.

Our MOLECULAR GENOMIC Services offer Sample processing and contract clinical services, genotyping, DNA/RNA extraction, NGS, expression analysis, Biorepository products and services.

We can help with all areas of regenerative medicine preclinical development as REPROCELL has expanded through a series of acquisitions over recent years creating a workflow including human tissue acquisition (BioServe®), RNA reprogramming (Stemgent®), 3D technologies (Alvetex®), and drug discovery (Biopta®) to the development of clinical stem cells.